AI pioneer Innoplexus and phytopharmaceutical company DrD are partnering toRead More
Partnering to unlock the true potential of cannabis in medical care
TiE Inflect 2018 announces Innoplexus AG as a 2018 TiE50 Finalist
April 23, 2018 – Eschborn – Innoplexus AG is excited to announce that it has been selected as a “2018 TiE50 Finalist” for the prestigious TiE50 Awards Program recognizing the world’s most innovative tech startups. This awards competition is part of TiE Inflect 2018, the world’s largest conference for tech entrepreneurs.
Innoplexus is helping organisations move to continuous decision-making by generating insights from structured and unstructured private and public data leveraging cutting edge Artificial Intelligence and Deep Learning technologies. “We focus on industries that need to constantly valuate and improve their efficiency, reduce cost and mitigate risk to keep up with the changing business environment. That’s why we leverage Artificial Intelligence and advanced analytics to shape the future of global finance, life sciences and pharmaceutical organizations,” says Dr. Gunjan Bhardwaj, Founder and CEO of Innoplexus AG. “We are very proud that our daily efforts of becoming the leading provider of AI solutions is recognized by TiE. That motivates our teams to even work harder to democratize data for empowered, inspired and faster decisions.”
“TiE50 has become a global brand that attracts thousands of tech startups worldwide. This year, we screened more than 7400 companies from 28 countries and selected the best-of- breed as our “2018 TiE50 Finalist.” These companies are finalists in the ultimate runoff for the 50 winners. Our program has gained notoriety over the past decade as a competition run with the highest level of integrity and vigorous screening and judging by domain experts.” – Kamal Anand, TiE50 Program Chair
“As a 26-year not-for- profit dedicated to fostering entrepreneurship and with a global footprint of half million entrepreneurs, enterprise executives, and investment professionals, we pride in the fact that we are one of very few competitions without any pay-to- play incentives” Ram K. Reddy, President, TiE Silicon Valley.
About TiE:
The Indus Entrepreneurs (TiE) is a not-for- profit founded in 1992 in the Silicon Valley by a group of successful entrepreneurs, corporate executives, and senior professionals. TiE is the world’s largest network of tech entrepreneurs. We are a cohesive global network with a footprint of half million entrepreneurs, enterprise executives, investment professionals, and other accomplished individuals. We operate from 60 cities in 18 countries. http://www.tieeco.org.
Featured News
Strategic partnership announcement: Innoplexus holding company Partex NV is pleased
Exciting News! Anavex Life Sciences and Partex NV Announce Strategic Partnership to Enhance Patient Experience.Anavex Life Sciences Corp. and Partex NV N.V. Group are pleased to announce…
AI supports targeted therapy recommendations fortumor diseases – BMBF funds
The treatment and support of patients with advanced tumor diseases is a complex task involving numerous disciplines. For the interdisciplinary…
Innoplexus and Innovatrix capital partner to bring about new risk-transfer
Artificial Intelligence (AI) pioneer Innoplexus and London based Parametric Insurance start-up, Innovatrix Capital, collaborating upon using AI & Machine Learning…
Innoplexus and Inflection Biosciences enter strategic collaboration based on Artificial
Innoplexus and Inflection Biosciences enter strategic collaboration based on Artificial Intelligence to expedite PIM kinase inhibitor development ESCHBORN, Germany, May 30,…
Parexel and Innoplexus Unveil Single Source of COVID-19 Information for
COVID-19 Clearinghouse enables direct access to latest COVID-19 datasets, publications, research and clinical trialsBOSTON and DURHAM, N.C. and ESCHBORN, Germany,…
New app for cancer patients
Das Eschborner Unternehmen Innoplexus hat eine neue App namens „Curia“ für Krebspatienten veröffentlicht. Mit dem Computerprogramm, das sich unentgeltlich herunterladen…
Innoplexus wins Silver Edison Award for OntosightⓇ Explore
Frankfurt, Germany, March 26, 2020 — Innoplexus AG has been honored with the Silver Edison Award 2020 for its proprietary…
AI CTP engine estimated failure for Biogen’s aducanumab
While drug development can be incredibly lucrative, it is a very risky business. German company Innoplexus has developed a domain-specific…
How can AI be leveraged for Clinical Trial Prediction?
Successful clinical trials occur at a ratio of 1 in 10, costing around $2-$3 billion, with drugs taking 10–12 years…
Innoplexus launches new Blockchain platform for Pharma innovation
If your loved one was diagnosed with a potentially fatal illness, wouldn’t you want all the information possible to be…